April 2022
Dr. Rosner is the Principal Investigator at the Rosner Laboratory and the Charles B. Huggins Professor of the Ben May Department of Cancer Research at the University of Chicago. After receiving her bachelor’s degree in biochemistry from Harvard University, and her Ph.D. degree in biochemistry from the Massachusetts Institute of Technology as a student […]
March 2022
Dr. Simon Haroutounian is the Chief of Clinical and Translational Research, Chief of Clinical Pain Research, and an Associate Professor of Anesthesiology for the Washington University Pain Center. Dr. Haroutounian obtained his BSc. Pharm and MSc. Pharm degrees, as well as his Ph.D., from the Hebrew University of Jerusalem. He has completed a Fulbright […]
February 2022
Dr. Yasmin Hurd is the Ward-Coleman Chair of Translational Neuroscience and the Director of the Addiction Institute, where Hurd is the only Black tenure-track basic science professor at Mount Sinai. Hurd holds appointments as faculty of Neuroscience, Psychiatry, Pharmacology and Systems Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City and is globally recognized for her translational research on the underlying neurobiology of substance […]
January 2022
Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber’s clinical research focuses on the application of neurocognitive models and brain imaging to better characterize risk factors for substance abuse and psychiatric conditions. […]
December 2021
Dr. Romero-Sandoval received a medical degree from Centro Universitario de Occidente, Quetzaltenango (Universidad de San Carlos de Guatemala) in 1999 and a Ph.D. degree in Neuroscience from Universidad de Alcalá de Henares, Spain, in 2003. He completed postdoctoral training at Wake Forest University, Winston Salem, NC (2003-2006) and Geisel Dartmouth Medical School, Lebanon, NH […]
November 2021
Professor Bryan is an internationally renowned social and health psychologist known for her research on HIV/STD prevention, exercise promotion, healthy eating, and most recently, the public health implications of legalized cannabis. She is a Professor and Associate Chair for Faculty Development in the Department of Psychology and Neuroscience at the University of Colorado Boulder […]
October 2021
Dr. Susan Weiss is the Director, Division of Extramural Research at the National Institute on Drug Abuse (NIDA), which oversees NIDA’s extramural programs, operations planning, and trans-NIH initiatives, such as the Adolescent Brain Cognitive Development (ABCD®) and HEALthy Brain Child Development (HBCD) studies, and the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. Dr. […]
September 2021
Gillian Schauer, PhD, MPH, is the Executive Director of the Cannabis Regulators Association (CANNRA) and a Senior Consultant on cannabis policy, epidemiology, and research translation. Her consulting has included work with the U.S. Centers for Disease Control and Prevention, the National Institute on Drug Abuse, and a number of U.S. states. Dr. Schauer is […]
July 2021
Dr. Ziva Cooper is the Director of the UCLA Cannabis Research Initiative in the Jane and Terry Semel Institute for Neuroscience and Human Behavior and Associate Professor in the Department of Psychiatry and Biobehavioral Sciences and Department of Anesthesiology at the David Geffen School of Medicine. Her current research involves understanding variables that influence […]
June 2021
Dr. Clayton W. Snell is the Senior Medical Science Liaison at Greenwich Biosciences (now part of Jazz Pharmaceuticals) and holds a Doctor of Pharmacy (PharmD) from the University of the Sciences in Philadelphia and possesses experience in professional medical affairs, healthcare services, and a demonstrated history in the pharmaceutical industry.
Dr. Clayton W. Snell, Cannabis […]
November 2022
Dr. Ari Greis is a board-certified physician who specializes in the non-operative treatment of spinal and musculoskeletal disorders. He is the director of the Medical Cannabis Department at Rothman Orthopedic Institute. He is interested in the treatment of chronic pain with cannabis as an alternative to opioids. Dr. Greis is a Clinical Assistant Professor […]
October 2022
Dr. Cinnamon Bidwell’s primary research focus is translational studies investigating the effects of abused drugs and how these effects impact psychological and physical health acutely and chronically. For over a decade, she has been building on her training in studies of drug dependence, neurobehavior, behavioral genetics, and co-occurring psychiatric disorders. She has expertise in […]
September 2022
Dr. Hollis Karoly is an Assistant Professor at Colorado State University, Fort Collins, Colorado specializing in Clinical Psychology and Neuroscience with a specialization in addictive disorders. Her research aims to characterize neural, molecular and behavioral mechanisms underlying the etiology of alcohol use disorders, in an effort to inform treatment development. More specifically, Dr. Karoly […]
July 2022
Professor Cecilia Hillard is the Director of the Neuroscience Research Center and Associate Dean for Research at the Medical College of Wisconsin. As a highly active researcher, Dr. Hillard’s laboratory primarily focuses on the pharmacology and biochemistry of cannabinoids and endocannabinoids. Her research focuses on cannabinoids, the receptors with which they interact, and the […]
June 2022
Dr. Jamie Lo
Jamie Lo, MD, MCR is an Associate Professor of Maternal Fetal Medicine, Obstetrics & Gynecology at Oregon Health & Science University and in the Division of Reproductive and Developmental Sciences at the Oregon National Primate Research Center. Her primary research mission is to determine the impact of environmental perturbations, including substance use, […]
May 2022
Cassandra Taylor, Ph.D. is a Chemist at U.S. Food and Drug Administration within the Center for Drug Evaluation and Research (CDER) and is a member of the Botanical Review Team (BRT) residing within the Office of Pharmaceutical Quality (OPQ) and serves as an expert resource on all botanical issues. Dr. Taylor received her B.S. […]